BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
68 hedge funds and large institutions have $61.6M invested in BioDelivery Sciences International, Inc. in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 8 closing their positions.
188% more call options, than puts
Call options by funds: $187K | Put options by funds: $65K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 70 → 68 (-2)
22% less capital invested
Capital invested by funds: $79.3M → $61.6M (-$17.8M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$6.95M |
| 2 |
AC
Armistice Capital
New York
|
+$1.87M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$845K |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$351K |
| 5 |
DMK
David M. Knott
|
+$281K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.9M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$1.97M |
| 3 |
Renaissance Technologies
New York
|
-$948K |
| 4 |
BC
Broadfin Capital
New York
|
-$832K |
| 5 |
B
Bailard
Foster City,
California
|
-$638K |
BDSI Hedge Fund Activity: Q1 2018 in Review
68 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2018, worth a combined $61.6M — down 22% from $79.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BDSI and 6 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 16 added.
The largest buyer was Avoro Capital Advisors, adding an estimated $6.95M. The largest seller was Bank of Montreal, exiting entirely with an estimated $2.9M sold.
- 68 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2018, down from 70 in Q4 2017.
- Funds reported $61.6M of BioDelivery Sciences International, Inc. stock for Q1 2018, down 22% quarter-over-quarter.
- 6 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2018 and 8 closed out, a net change of -2 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2018 was Avoro Capital Advisors, an estimated $6.95M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2018 was Bank of Montreal, an estimated $2.9M sold.
Based on aggregated 13F filings for Q1 2018.